دورية أكاديمية

Effect of infusion of monoclonal antibodies to tumour necrosis factor-receptor super family 25 on graft rejection in allo-immune mice receiving autologous marrow transplantation.

التفاصيل البيبلوغرافية
العنوان: Effect of infusion of monoclonal antibodies to tumour necrosis factor-receptor super family 25 on graft rejection in allo-immune mice receiving autologous marrow transplantation.
المؤلفون: Gorczynski RM; Transplant Research Division, University Health Network and Toronto General Hospital, Toronto, ON, Canada.; Department of Immunology and Surgery, University of Toronto, Toronto, ON, Canada., Sadozai H; Transplant Research Division, University Health Network and Toronto General Hospital, Toronto, ON, Canada., Zhu F; Transplant Research Division, University Health Network and Toronto General Hospital, Toronto, ON, Canada., Khatri I; Transplant Research Division, University Health Network and Toronto General Hospital, Toronto, ON, Canada.
المصدر: Immunology [Immunology] 2017 Apr; Vol. 150 (4), pp. 418-431. Date of Electronic Publication: 2016 Dec 22.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0374672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2567 (Electronic) Linking ISSN: 00192805 NLM ISO Abbreviation: Immunology Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford : Blackwell Scientific Publications
مواضيع طبية MeSH: Bone Marrow Transplantation*, Antibodies, Monoclonal/*therapeutic use , Graft Rejection/*prevention & control , Immunotherapy/*methods , T-Lymphocytes, Regulatory/*immunology, Allografts/immunology ; Animals ; Cells, Cultured ; Graft Rejection/immunology ; Graft Survival ; Humans ; Immune Tolerance ; Isoantibodies/blood ; Male ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Receptors, Tumor Necrosis Factor, Member 25/immunology ; Transplantation, Homologous
مستخلص: Significant barriers to transplantation exist for individuals who are pre-sensitized to donor antigen and have high titres of donor-reactive antibody. We report the effect of autologous bone marrow transplantation (BMTx) after myeloablation in pre-sensitized mice along with the use of monoclonal antibodies (mAbs) to tumour necrosis factor-receptor super family 25 (TNFRSF25), expressed on regulatory T (Treg) cells. C57BL/6 mice, which had been sensitized earlier with BALB/c skin allografts, received secondary BALB/c grafts after the primary grafts had been rejected. Subsequently, recipient mice underwent myeloablation with cyclophosphamide and busulphan and were injected with T-cell-depleted bone marrow from CD45.1 congenic donors (BMTx). Recipient mice underwent immunosuppressive treatment with rapamycin. A subgroup of mice was also treated with mAbs to TNFRSF25. Control mice were pre-sensitized mice that received cyclophosphamide and busulphan followed by rapamycin. BMTx-treated mice had significantly prolonged skin graft survival versus control mice. These mice also showed attenuated donor-specific mixed lymphocyte co-culture responses relative to controls, increased splenic Treg cells and markedly diminished serum anti-donor IgG. Infusion of anti-TNFRSF25 mAbs further augmented graft survival and increased graft-infiltrating Treg cells. These mAbs also expanded murine and human Treg cells in vitro with the capacity to attenuate mixed lymphocyte co-cultures using fresh peripheral blood mononuclear cells. Overall, this study delineates the roles of autologous BMTx and anti-TNFRSF25 mAbs in expanding Treg cells and attenuating alloimmune responses in pre-sensitized mice.
(© 2016 John Wiley & Sons Ltd.)
References: N Engl J Med. 2008 Jul 17;359(3):242-51. (PMID: 18635429)
Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4615-9. (PMID: 9114039)
J Exp Med. 2008 Oct 27;205(11):2457-64. (PMID: 18824582)
Eur J Immunol. 2014 Jun;44(6):1728-36. (PMID: 24700192)
J Immunol. 2005 Apr 15;174(8):4985-90. (PMID: 15814728)
J Exp Med. 2008 May 12;205(5):1037-48. (PMID: 18411341)
J Immunol. 2007 Apr 1;178(7):4033-8. (PMID: 17371957)
J Clin Invest. 2010 Oct;120(10):3629-40. (PMID: 20890040)
Transpl Immunol. 2011 Dec;25(4):187-93. (PMID: 21801836)
Blood. 1989 Nov 1;74(6):2203-11. (PMID: 2478224)
Transplant Proc. 2014 Jan-Feb;46(1):3-8. (PMID: 24216174)
Leuk Res. 1989;13(9):791-7. (PMID: 2477647)
Blood. 2008 Mar 15;111(6):3266-75. (PMID: 17827394)
Immunity. 2008 Jul 18;29(1):79-89. (PMID: 18571443)
Transplantation. 2014 Dec 27;98(12):1271-8. (PMID: 25340612)
Transplantation. 2008 Dec 27;86(12):1754-61. (PMID: 19104417)
J Exp Med. 2008 May 12;205(5):1049-62. (PMID: 18411337)
Immunol Rev. 2014 Mar;258(1):183-207. (PMID: 24517434)
Gene. 1997 Dec 19;204(1-2):35-46. (PMID: 9434163)
Clin Transplant. 2014 Apr;28(4):494-507. (PMID: 24621089)
Gastroenterology. 2008 Aug;135(2):552-67. (PMID: 18598698)
J Virol. 1995 Mar;69(3):1895-902. (PMID: 7853531)
Immunity. 1997 Jan;6(1):79-88. (PMID: 9052839)
Transplantation. 2014 Dec 27;98(12):1262-70. (PMID: 25286051)
Blood. 2009 Jan 1;113(1):214-23. (PMID: 18824594)
Tissue Antigens. 2011 Jan;77(1):3-8. (PMID: 21155718)
J Transplant. 2012;2012:193724. (PMID: 22577514)
Med Clin North Am. 2010 Nov;94(6):1241-54, xii. (PMID: 20951281)
J Clin Invest. 2014 Mar;124(3):1052-6. (PMID: 24509079)
J Clin Invest. 2011 Feb;121(2):463-4; author reply 465. (PMID: 21285518)
Expert Rev Clin Immunol. 2015 Feb;11(2):195-204. (PMID: 25543845)
Nat Immunol. 2011 Feb;12(2):151-9. (PMID: 21217761)
J Am Soc Nephrol. 2010 Aug;21(8):1398-406. (PMID: 20634297)
معلومات مُعتمدة: Canada CIHR
فهرسة مساهمة: Keywords: bone marrow transplantation; donor-reactive antibodies; myeloablation; regulatory T cells; tumour necrosis factor-receptor super family 25
المشرفين على المادة: 0 (Antibodies, Monoclonal)
0 (Isoantibodies)
0 (Receptors, Tumor Necrosis Factor, Member 25)
0 (Tnfrsf25 protein, mouse)
تواريخ الأحداث: Date Created: 20161119 Date Completed: 20170531 Latest Revision: 20181113
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC5343351
DOI: 10.1111/imm.12693
PMID: 27859243
قاعدة البيانات: MEDLINE